EphA2-targeted therapy delivers chemo directly to ovarian cancer cells

With a novel therapeutic delivery system, a research team led by scientists at The University of Texas M. D. Anderson Cancer Centre has successfully targeted a protein that is over-expressed in ovarian cancer cells. Using the EphA2 protein as a molecular homing mechanism, chemotherapy was delivered in a highly selective manner in preclinical models of ovarian cancer, the researchers report in the 29 July issue of the Journal of the National Cancer Institute...

Read the whole article on

More from